Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.
Northwestern Medicine scientists have proven an old therapeutic focus for Huntington’s disease wrong, and they propose a new one in its place.
Northwestern Medicine scientists have expanded the understanding of how myelodysplastic syndromes develop.
Depleting an enzyme called GM3 synthase with gene therapy may help diabetics heal wounds faster.
Navdeep Chandel, PhD, David W. Cugell Distinguished Professor in Medicine-Pulmonary and Cell and Molecular Biology, focuses on the role of metabolism and signaling in disease.
Prostate cancer cells producing too much PIM1 are particularly sensitive to the inhibition of a protein called polo-like kinase (PLK1).
Northwestern Medicine scientists demonstrate that exposure to air pollution causes a stress response characterized by elevation in the level of the stress hormone adrenaline.
Daniela Menichella, MD, PhD, assistant professor in Neurology, studies the mechanism and role of the protein chemokine SDF-1 and its receptor CXCR4 in Painful Diabetic Neuropathy.
Scientists from Northwestern Medicine and the University of Chicago identified elevated levels of a regulatory protein called beta-catenin in the T-cells of patients with colon cancer.
Robin Skory, an MD/PhD student, worked in the lab of Teresa Woodruff, PhD, to study follicle development and fertility preservation.
Notifications